Natixis Downgrades Novo Nordisk (NVO) to Neutral
Tweet
Share
E-mailGet Alerts NVO Hot Sheet
Price: $46.14 --0%
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
8 Buy, 17 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Natixis downgraded Novo Nordisk (NYSE: NVO) from Buy to Neutral.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $158.89 yesterday.
For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.
Shares of Novo Nordisk closed at $158.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- Kepler Cheuvreux Downgrades Avantium N.V (AVTX:NA) to Reduce
- Goldman Sachs Downgrades Kuaishou Technology (1024:HK) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
